Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)

EyePoint, Inc. has successfully completed enrollment of over 480 patients in its global Phase 3 COMO and CAPRI trials evaluating DURAVYU™ (vorolanib intravitreal insert) for diabetic macular edema (DME). Enrollment finished ahead of schedule within five months, reflecting strong interest among the retinal specialist community. DURAVYU is a sustaine…

HII Reports Second Quarter 2026 Results

HII Reports Second Quarter 2026 Results

Huntington Ingalls Industries (NYSE: HII) reported robust second quarter 2026 results with revenues rising 10.9% year-over-year to $3.4 billion and net earnings increasing by 36.8% to $208 million ($5.27 diluted EPS). The company raised its full-year 2026 shipbuilding revenue guidance to $10.2-$10.4 billion and improved the lower end of the shipbui…

LKQ Corporation Announces Results for Second Quarter 2026

LKQ Corporation Announces Results for Second Quarter 2026

LKQ Corporation reported second quarter 2026 results showing a 3% revenue decline to $3.4 billion, with net income and adjusted net income decreasing compared to prior year. North America segment achieved positive organic growth driven by increased alternative parts usage, while Europe underperformed due to ERP implementation issues. The company co…

AMC Global Media Inc. Reports Second Quarter 2026 Results

AMC Global Media Inc. Reports Second Quarter 2026 Results

AMC Global Media Inc. reported its Q2 2026 financial results, emphasizing a new global co-exclusive content licensing agreement with Netflix for the streaming rights to the entire Walking Dead Universe, generating $500 million over five years. While the company renewed key distribution agreements and increased full-year guidance, Q2 revenues declin…

Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology

Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology

Mangoceuticals, Inc. has entered into a business combination agreement with Nuclea Energy Inc., a Canadian advanced nuclear technology firm developing the Morpheus lead-cooled microreactor. The transaction will bring Nuclea public via Mangoceuticals’ Nasdaq listing, supporting Nuclea's advancement toward commercialization amid growing electricity d…

Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Beyond Air, a NASDAQ-listed commercial-stage medical device and biopharmaceutical company, announced a private placement offering of up to $30.1 million at-the-market under Nasdaq rules. The financing involves the sale of common stock, pre-funded warrants, and accompanying Series A and B warrants to institutional healthcare investors and company in…

HUTCHMED Reports 2026 Interim Results

HUTCHMED Reports 2026 Interim Results

HUTCHMED reported robust growth in China product sales led by ELUNATE® and SULANDA®, with over 40% sales increase, and strong ex-US sales growth for FRUZAQLA®. The company maintained profitability with $15.9 million net income amid higher R&D investment and a strong cash position of $1.37 billion. Multiple first-in-class Antibody-Targeted Therapy C…

Allegro MicroSystems Reports First Quarter 2027 Results

Allegro MicroSystems Reports First Quarter 2027 Results

Allegro MicroSystems, Inc. announced its financial results for the first quarter of fiscal 2027, showing strong momentum with $259 million in sales, a 27% year-over-year increase. The company returned to profitability with GAAP EPS of $0.08 compared to a loss the prior year, and non-GAAP EPS grew over 2.5 times to $0.23. Growth was led by data cent…

Shoals Technologies Group, Inc. Announces Participation in Upcoming Events for the Investor Community

Shoals Technologies Group, Inc. Announces Participation in Upcoming Events for the Investor Community

Shoals Technologies Group, a Nasdaq-listed leader in electrical infrastructure for the energy transition market, announced its participation in several upcoming virtual and in-person investor events hosted by prominent financial institutions between August and October 2026. These events will involve fireside chats, conferences, and roadshows focuse…

Colliers Reports Second Quarter Results

Colliers Reports Second Quarter Results

Colliers International Group Inc. announced robust second quarter 2026 financial results, showing a 17% increase in consolidated revenues to $1.57 billion and a 14% rise in Adjusted EBITDA to $205.3 million compared to Q2 2025. Adjusted EPS increased 6% to $1.83. The company's diversified business model continues to fuel growth across Commercial Re…

INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform

INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform

INmune Bio has established a Scientific Advisory Board composed of global experts to support the late-stage clinical and regulatory development of Ebstrocel, a treatment for recessive dystrophic epidermolysis bullosa (RDEB), and to guide expansion of its proprietary CORDStrom™ mesenchymal stromal cell platform into new therapeutic areas. The SAB wi…

Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Phathom Pharmaceuticals announced an 88% year-over-year increase in Q2 2026 net revenues to $74.3 million driven by growth in VOQUEZNA prescriptions. The company reduced operating expenses by 33% compared to Q2 2025 and achieved operating profitability excluding stock-based compensation. Phathom plans to initiate a Phase 3 clinical trial evaluating…

Martin Marietta Reports Second-Quarter 2026 Results

Martin Marietta Reports Second-Quarter 2026 Results

Martin Marietta Materials, Inc. reported second-quarter 2026 results with a 21% increase in revenues to a new record of $1.947 billion and a 13% growth in adjusted EBITDA from continuing operations. The company raised its full-year 2026 revenue guidance to $7.2 billion to $7.4 billion while reaffirming adjusted EBITDA guidance. Key initiatives incl…

ADT Reports Second Quarter 2026 Results

ADT Reports Second Quarter 2026 Results

ADT Inc. reported second quarter 2026 results showing a 2% revenue increase to $1.3 billion, significant cash flow growth with operating cash flow up 18% and adjusted free cash flow up 48%. The company repurchased $478 million of shares and returned $684 million to shareholders in the first half of 2026. ADT raised its full-year 2026 financial outl…

Brookfield Infrastructure Reports Strong Second Quarter 2026 Results

Brookfield Infrastructure Reports Strong Second Quarter 2026 Results

Brookfield Infrastructure Partners L.P. reported a strong second quarter for 2026, delivering 10% growth in funds from operations (FFO) per unit compared to the prior year. The company saw significant contributions from its data and midstream segments, with strong organic growth driven by inflation-linked utilities rate increases, increased volumes…